Stock(600222)Hot line:010-61006450

About Us


Leadingpharm (stock code: 600222) was established in 2005. It is a high-tech enterprise providing pharmacy pre-clinical research, clinical CRO and CDMO services worldwide. It has been rated as "China’s Top 10 Pharmaceutical R&D Enterprises " for many years (ranked first in 2019). The company is headquartered in Beijing Zhongguancun High-tech Park and has established new drug screening and testing platform, drug evaluation platform (animal room, certified by GLP, AAALAC, CNAS), large molecule pilot and large-scale production platform, small molecule CMC research and production platform, cell technology platform and clinical CRO platform in Life Zhengzhou. The six platforms comply with international standards (FDA, EMA and NMPAGMP) , forming " Leadingpharm CXO" whole industry chain service system. The combination of imitation and creation, driven by dual engines, can provide customers with diversified services throughout the pharmaceutical research and development.



  • Company News

Cooperation and Communication || Exploratory Mission of Pharnex Came to Leadingpharm for Visit and Communication

On April 17, a delegation from Pharnex, composed of Mr. Wang Bo, founder of Pharnex; Ms. Yan Jie, Chairman of Hankang Medicine, Ms. Lu Donghong, Technical Deputy Director of the All-China Federation of Industry and Commerce and representatives of nearly 20 leading pharmaceutical companies in the fields of pharmaceutical investment, innovative drug research and development, import and export trade, came to Leadingpharm for visit and communication.


Leadingpharm Established Strategic Partnership with NeoTrident to Create an Industry Benchmark Together for Intelligent Change

On April 16, the new Leadingpharm formally signed a strategic cooperation agreement with NeoTrident.


Strategic Cooperation || Leadingpharm and the School of Chemistry of Beijing Normal University

In this tulip blooming season, on the afternoon of April 14,Leadingpharm and the School of Chemistry of Beijing Normal University formally signed a framework agreement of strategic cooperation.